Spectrometric Smartphone-Based System for Ibuprofen Quantification in Commercial Dosage Tablets

Empreu sempre aquest identificador per citar o enllaçar aquest ítem http://hdl.handle.net/10045/92507
Información del item - Informació de l'item - Item information
Títol: Spectrometric Smartphone-Based System for Ibuprofen Quantification in Commercial Dosage Tablets
Autors: Aguirre Pastor, Miguel Ángel | Long, Kenneth D. | Cunningham, Brian T.
Grups d'investigació o GITE: Espectroscopía Atómica-Masas y Química Analítica en Condiciones Extremas
Centre, Departament o Servei: Universidad de Alicante. Departamento de Química Analítica, Nutrición y Bromatología | Universidad de Alicante. Instituto Universitario de Materiales
Paraules clau: Analytical chemistry | Absorption spectroscopy | Image analysis | Regulatory science | Analysis
Àrees de coneixement: Química Analítica
Data de publicació: 15-de març-2019
Editor: Elsevier
Citació bibliogràfica: Journal of Pharmaceutical Sciences. 2019, 108(8): 2593-2598. doi:10.1016/j.xphs.2019.03.010
Resum: A rapid and portable analytical methodology has been developed for ibuprofen (IBU) quantification in commercial dosage tablets using a spectrometric smartphone-based system. The analytical methodology employs point-of-use approaches both for sample preparation and detection, demonstrating its potential utility for portable quality control of pharmaceutical products. In this work, IBU is dissolved in methanol and then treated with a Co(II) aqueous solution, forming a blue complex which is extractable by dispersive liquid-liquid microextraction. Then, the sample’s absorption spectrum is directly measured by a spectrometric smartphone-based system using cartridge made of polyoxymethylene for solvent compatibility. The main experimental factors affecting the dispersive liquid-liquid microextraction of Co-IBU complex were optimized using a multivariate analysis. Under optimized conditions, a working range between 20 and 80 μg mL−1 was obtained with a correlation coefficient of 0.996 for 5 calibration points. The limit of detection and limit of quantification obtained were 4 and 12 μg mL−1, respectively. The performance of the proposed methodology was evaluated in commercial tablet dosage forms, and the results demonstrate the ability of the method to determine IBU in samples representative of those used in real-world quality control applications. Recovery values between 97% and 105% were obtained, which are comparable to those obtained via standard titrimetric methodology.
Patrocinadors: The authors would like to acknowledge the National Science Foundation for their support of this work via Grant no. CBET 12-64377. M.A.A. is grateful to Generalitat Valenciana (Spain) (APOSTD/2016/076) for his Post-Doctoral fellowship and the financial support from the European Social Fund (ESF). K.D.L. is supported by a Ruth L. Kirschstein Pre-Doctoral Fellowship (NIH F30AI122925).
URI: http://hdl.handle.net/10045/92507
ISSN: 0022-3549 (Print) | 1520-6017 (Online)
DOI: 10.1016/j.xphs.2019.03.010
Idioma: eng
Tipus: info:eu-repo/semantics/article
Drets: © 2019 Published by Elsevier Inc. on behalf of the American Pharmacists Association
Revisió científica: si
Versió de l'editor: https://doi.org/10.1016/j.xphs.2019.03.010
Apareix a la col·lecció: INV - SP-BG - Artículos de Revistas

Arxius per aquest ítem:
Arxius per aquest ítem:
Arxiu Descripció Tamany Format  
Thumbnail2019_Aguirre_etal_JPharmaceuticalSci_InPress.pdfIn Press (acceso restringido)807,19 kBAdobe PDFObrir     Sol·licitar una còpia


Tots els documents dipositats a RUA estan protegits per drets d'autors. Alguns drets reservats.